Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moshe Talpaz

Showing results (111-120 of 263) with videos related to

Pageof 27
Sort By:
Cancer|February 8, 2006
Staging of chronic myeloid leukemia in the imatinib era: an evaluation of the World Health Organization proposalJorge E Cortes, Moshe Talpaz, Susan O'Brien, et al.
Cancer|September 16, 2003
Effects of age on prognosis with imatinib mesylate therapy for patients with Philadelphia chromosome-positive chronic myelogenous leukemiaJorge Cortes, Moshe Talpaz, Susan O'Brien, et al.
Cancer|June 23, 2005
Significance of myelofibrosis in early chronic-phase, chronic myelogenous leukemia on imatinib mesylate therapyHagop M Kantarjian, Carlos E Bueso-Ramos, Moshe Talpaz, et al.
Neoplasia (New York, N.Y.)|December 18, 2017
Usp9x Promotes Survival in Human Pancreatic Cancer and Its Inhibition Suppresses Pancreatic Ductal Adenocarcinoma In Vivo Tumor GrowthAnupama Pal, Michele Dziubinski, Marina Pasca Di Magliano, et al.
Annals of Hematology|December 31, 2017
Outcomes of previously untreated elderly patients with AML: a propensity score-matched comparison of clofarabine vs. FLAGGianni B Scappaticci, Bernard L Marini, Victoria R Nachar, et al.
Leukemia & Lymphoma|January 14, 2017
Induction of p53 suppresses chronic myeloid leukemiaLuke F Peterson, Miao-Chia Lo, Yihong Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2004
Pharmacokinetics and pharmacodynamics of imatinib in a phase I trial with chronic myeloid leukemia patientsBin Peng, Michael Hayes, Debra Resta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2009
Phase II trial of combination therapy with bortezomib, pegylated liposomal doxorubicin, and dexamethasone in patients with newly diagnosed myelomaAndrzej J Jakubowiak, Tara Kendall, Ammar Al-Zoubi, et al.
Blood|August 24, 2010
Acquired genomic copy number aberrations and survival in adult acute myelogenous leukemiaBrian Parkin, Harry Erba, Peter Ouillette, et al.
Blood|November 2, 2002
Efficacy of the farnesyl transferase inhibitor R115777 in chronic myeloid leukemia and other hematologic malignanciesJorge Cortes, Maher Albitar, Deborah Thomas, et al.
Pageof 27

Showing results (111-120 of 263) with videos related to

Sort By:
Pageof 27
Cancer|February 8, 2006
Staging of chronic myeloid leukemia in the imatinib era: an evaluation of the World Health Organization proposalJorge E Cortes, Moshe Talpaz, Susan O'Brien, et al.
Cancer|September 16, 2003
Effects of age on prognosis with imatinib mesylate therapy for patients with Philadelphia chromosome-positive chronic myelogenous leukemiaJorge Cortes, Moshe Talpaz, Susan O'Brien, et al.
Cancer|June 23, 2005
Significance of myelofibrosis in early chronic-phase, chronic myelogenous leukemia on imatinib mesylate therapyHagop M Kantarjian, Carlos E Bueso-Ramos, Moshe Talpaz, et al.
Neoplasia (New York, N.Y.)|December 18, 2017
Usp9x Promotes Survival in Human Pancreatic Cancer and Its Inhibition Suppresses Pancreatic Ductal Adenocarcinoma In Vivo Tumor GrowthAnupama Pal, Michele Dziubinski, Marina Pasca Di Magliano, et al.
Annals of Hematology|December 31, 2017
Outcomes of previously untreated elderly patients with AML: a propensity score-matched comparison of clofarabine vs. FLAGGianni B Scappaticci, Bernard L Marini, Victoria R Nachar, et al.
Leukemia & Lymphoma|January 14, 2017
Induction of p53 suppresses chronic myeloid leukemiaLuke F Peterson, Miao-Chia Lo, Yihong Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2004
Pharmacokinetics and pharmacodynamics of imatinib in a phase I trial with chronic myeloid leukemia patientsBin Peng, Michael Hayes, Debra Resta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2009
Phase II trial of combination therapy with bortezomib, pegylated liposomal doxorubicin, and dexamethasone in patients with newly diagnosed myelomaAndrzej J Jakubowiak, Tara Kendall, Ammar Al-Zoubi, et al.
Blood|August 24, 2010
Acquired genomic copy number aberrations and survival in adult acute myelogenous leukemiaBrian Parkin, Harry Erba, Peter Ouillette, et al.
Blood|November 2, 2002
Efficacy of the farnesyl transferase inhibitor R115777 in chronic myeloid leukemia and other hematologic malignanciesJorge Cortes, Maher Albitar, Deborah Thomas, et al.
Pageof 27